Molecular biomarkers for the early detection of ovarian cancer
R Zhang, MKY Siu, HYS Ngan, KKL Chan - International Journal of …, 2022 - mdpi.com
Ovarian cancer is the deadliest gynecological cancer, leading to over 152,000 deaths each
year. A late diagnosis is the primary factor causing a poor prognosis of ovarian cancer and …
year. A late diagnosis is the primary factor causing a poor prognosis of ovarian cancer and …
[HTML][HTML] Updates and new options in advanced epithelial ovarian cancer treatment
Financial Disclosure Ernst Lengyel disclosed that money was paid to his institution from
AbbVie (funding preclinical studies), NCI (RO1 grants), and the Ovarian Cancer Research …
AbbVie (funding preclinical studies), NCI (RO1 grants), and the Ovarian Cancer Research …
Integrating artificial intelligence and nanotechnology for precision cancer medicine
Artificial intelligence (AI) and nanotechnology are two fields that are instrumental in realizing
the goal of precision medicine—tailoring the best treatment for each cancer patient. Recent …
the goal of precision medicine—tailoring the best treatment for each cancer patient. Recent …
Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer
CAK Borrebaeck - Nature Reviews Cancer, 2017 - nature.com
Interest in precision diagnostics has been fuelled by the concept that early detection of
cancer would benefit patients; that is, if detected early, more tumours should be resectable …
cancer would benefit patients; that is, if detected early, more tumours should be resectable …
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group
D Timmerman, B Van Calster, A Testa, L Savelli… - American journal of …, 2016 - Elsevier
Background Accurate methods to preoperatively characterize adnexal tumors are pivotal for
optimal patient management. A recent metaanalysis concluded that the International …
optimal patient management. A recent metaanalysis concluded that the International …
Current and emerging methods for ovarian cancer screening and diagnostics: a comprehensive review
Simple Summary Ovarian high-grade serous carcinoma (HGSC) has a 5-year survival rate
of less than 50%, making it one of the most lethal gynecological cancers for women in the …
of less than 50%, making it one of the most lethal gynecological cancers for women in the …
The role of CA 125 as tumor marker: biochemical and clinical aspects
CA 125 also known as mucin 16 or MUC16 is a large membrane glycoprotein belonging to
the wide mucin family, encoded by the homonymous MUC16 gene. Following its discovery …
the wide mucin family, encoded by the homonymous MUC16 gene. Following its discovery …
Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis
J Kaijser, A Sayasneh, K Van Hoorde… - Human reproduction …, 2014 - academic.oup.com
BACKGROUND Characterizing ovarian pathology is fundamental to optimizing
management in both pre-and post-menopausal women. Inappropriate referral to oncology …
management in both pre-and post-menopausal women. Inappropriate referral to oncology …
Validation of American college of radiology ovarian-adnexal reporting and data system ultrasound (O-RADS US): analysis on 1054 adnexal masses
L Cao, M Wei, Y Liu, J Fu, H Zhang, J Huang, X Pei… - Gynecologic …, 2021 - Elsevier
Objective To assess the diagnostic performance and inter-observer agreement of the
American College of Radiology (ACR) Ovarian-Adnexal Reporting and Data System …
American College of Radiology (ACR) Ovarian-Adnexal Reporting and Data System …
First international consensus report on adnexal masses: management recommendations
The First International Consensus Conference on Adnexal Masses was convened to
thoroughly examine the state of the science and to formulate recommendations for clinical …
thoroughly examine the state of the science and to formulate recommendations for clinical …